Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Thymoma A Population-Based Study of the Management and Outcomes for the Province of British Columbia

Thymoma A Population-Based Study of the Management and Outcomes for the Province of British Columbia ORIGINAL ARTICLE Thymoma A Population-Based Study of the Management and Outcomes for the Province of British Columbia Caroline Mariano, MD,* Diana N. Ionescu, MD,† Winson Y. Cheung, MD,* Rola H. Ali, MD,† Janessa Laskin, MD,* Ken Evans, MD,§ Hannah Carolan, MD,‡ and Nevin Murray, MD* hymomas are rare tumors with an incidence of approxi- Introduction: Thymomas are rare neoplasms with variable clinical Tmately 0.15 cases per 100,000 person years. Unfortunately, behavior. Our primary study aim was to analyze treatment practices little is known about the etiology of these malignancies and and outcomes in a population-based cohort of thymoma patients. their clinical behavior can be quite variable. There has been We hypothesized that stage I and II thymomas would have high cure widespread debate about their optimal classification. In 1995, rates with resection and adjuvant radiation, whereas locally advanced the World Health Organization (WHO) proposed a new patho- cases would benefit from multimodality therapy. logic staging system that has since been widely accepted and Methods: All patients, diagnosed with thymoma or thymic carci- 3–5 has been proven to have prognostic value. noma in British Columbia between 1994 and 2009, were identified The management of these tumors also continues to using http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Thymoma A Population-Based Study of the Management and Outcomes for the Province of British Columbia

Journal of Thoracic Oncology , Volume 8 (1) – Jan 1, 2013

Loading next page...
 
/lp/wolters-kluwer-health/thymoma-a-population-based-study-of-the-management-and-outcomes-for-gsM0sgyZeX

References (29)

Copyright
Copyright © 2012 by the International Association for the Study of Lung Cancer
ISSN
1556-0864
DOI
10.1097/JTO.0b013e318276241c
pmid
23242441
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Thymoma A Population-Based Study of the Management and Outcomes for the Province of British Columbia Caroline Mariano, MD,* Diana N. Ionescu, MD,† Winson Y. Cheung, MD,* Rola H. Ali, MD,† Janessa Laskin, MD,* Ken Evans, MD,§ Hannah Carolan, MD,‡ and Nevin Murray, MD* hymomas are rare tumors with an incidence of approxi- Introduction: Thymomas are rare neoplasms with variable clinical Tmately 0.15 cases per 100,000 person years. Unfortunately, behavior. Our primary study aim was to analyze treatment practices little is known about the etiology of these malignancies and and outcomes in a population-based cohort of thymoma patients. their clinical behavior can be quite variable. There has been We hypothesized that stage I and II thymomas would have high cure widespread debate about their optimal classification. In 1995, rates with resection and adjuvant radiation, whereas locally advanced the World Health Organization (WHO) proposed a new patho- cases would benefit from multimodality therapy. logic staging system that has since been widely accepted and Methods: All patients, diagnosed with thymoma or thymic carci- 3–5 has been proven to have prognostic value. noma in British Columbia between 1994 and 2009, were identified The management of these tumors also continues to using

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: Jan 1, 2013

There are no references for this article.